In one paragraphArticle in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
19 authors.
Franziska AdermannLaboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena Humboldtstraße 10 07743 Jena Germany ulrich.schubert@uni-jena.de.ORCID https://orcid.org/0009-0003-4012-7567 Thorben KöhlerLaboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena Humboldtstraße 10 07743 Jena Germany ulrich.schubert@uni-jena.de.ORCID https://orcid.org/0009-0002-4912-5747 Lea C KlepschLaboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena Humboldtstraße 10 07743 Jena Germany ulrich.schubert@uni-jena.de.ORCID https://orcid.org/0009-0009-3849-1670 Bärbel Beringer-SiemersLaboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena Humboldtstraße 10 07743 Jena Germany ulrich.schubert@uni-jena.de.
Carolin KellnerLaboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena Humboldtstraße 10 07743 Jena Germany ulrich.schubert@uni-jena.de.
Steffi StumpfLaboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena Humboldtstraße 10 07743 Jena Germany ulrich.schubert@uni-jena.de.
David PretzelLaboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena Humboldtstraße 10 07743 Jena Germany ulrich.schubert@uni-jena.de.
Lisa JäpelLaboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena Humboldtstraße 10 07743 Jena Germany ulrich.schubert@uni-jena.de.
Zehra Tuğçe Gür MazDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University 06560 Ankara Turkey.
Philipp DahlkeDepartment of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena Philosophenweg 14 07743 Jena Germany.
Antje VollrathLaboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena Humboldtstraße 10 07743 Jena Germany ulrich.schubert@uni-jena.de.ORCID https://orcid.org/0000-0001-5801-7743 Stephanie SchubertLaboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena Humboldtstraße 10 07743 Jena Germany ulrich.schubert@uni-jena.de.ORCID https://orcid.org/0000-0001-9527-7763 Erden BanogluDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University 06560 Ankara Turkey.
Oliver WerzJena Center for Soft Matter (JCSM), Friedrich Schiller University Jena Philosophenweg 7 07743 Jena Germany.
Ulrich S SchubertLaboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena Humboldtstraße 10 07743 Jena Germany ulrich.schubert@uni-jena.de.ORCID https://orcid.org/0000-0003-4978-4670 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Chronic inflammatory conditions remain a major therapeutic challenge, driving the demand for more selective and well-tolerated treatment options. The 2-amino-1,3,4-oxadiazole-based TG554, a novel and highly potent inhibitor of microsomal prostaglandin E
Identifiers
PMID42170092
PMCPMC13187903
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390